新生GTP合成是对拦截大脑转移的代谢脆弱性
Agata M Kieliszek1, Daniel Mobilio1, Blessing I Bassey-Archibong2
1Centre for Discovery in Cancer Research, McMaster University, Hamilton, ON, Canada; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada.
Cell reports. Medicine
|October 4, 2024
概括
向因氨酸单酸脱酶 (IMPDH) 提供了针对大脑转移 (BM) 的新策略. 抑制IMPDH可以减少大脑转移 - - 启动细胞生长和形成,提供了除了息治疗之外的希望.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 代谢途径 代谢途径
背景情况:
- 大脑转移 (BM) 的预后不好,治疗选择有限.
- 向大脑转移启动细胞 (BMIC) 是一个有前途的治疗策略.
- 对于BMICs来说,可用药物的目标仍然很少.
研究的目的:
- 为了确定脑转移的新型治疗点.
- 为了研究伊诺辛单酸脱酶 (IMPDH) 在BM发育中的作用.
- 评估IMPDH作为BM治疗的潜在药物标.
主要方法:
- 连接性 BMIC基因表达特征的地图分析.
- IMPDH的药理和遗传抑制.
- 在体外和体内研究BMIC扩散和BM形成.
- 代谢分析和CRISPR淘汰研究.
主要成果:
- 连接地图分析确定IMPDH是BMIC的一个关键目标.
- IMPDH抑制 (药理和遗传) 在体外减少了BMIC的扩散.
- 在体内,IMPDH抑制减弱了大脑转移的形成.
- 通过IMPDH进行的新生GTP合成被证实是BM的代谢脆弱性.
结论:
- 伊诺辛单酸脱酶 (IMPDH) 是对大脑转移的验证治疗点.
- 向IMDH为BM患者提供了潜在的替代治疗策略.
- 这项研究提供了一种以表型为指导的方法来确定新的癌症治疗方法.
相关概念视频
GTPases and their Regulation
8.3K
Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒ small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...
Large G-proteins,...
8.3K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Drugs that Destabilize Microtubules
1.9K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K


